北京商报讯（记者 丁宁）11月12日晚间，北大医药（000788）发布公告称，公司于近日经有关部门核 实，获悉公司董事长、总裁徐晰人因涉嫌刑事犯罪，已被重庆市江北区人民检察院批准逮捕。 北大医药表示，截至公告披露日，公司董事陈岳忠根据授权代为行使董事长职责，公司常务副总裁余孟 川根据授权代为行使总裁及法定代表人职责。公司控制权未发生变化，公司董事会运作正常，公司财务 及生产经营管理情况正常。公司将持续关注上述事项的后续情况，并严格按照有关法律、法规的规定和 要求，及时履行信息披露义务并提示相关风险。 ...

校 对： 吕久彪 百万用户都在看 刚刚！"18罗汉"，突然异动！ 直线拉升！三大利好，集中来袭！ 美国，传出大消息！ 特朗普，最新发声！ 涨停潮！A股盘中，集体拉升！ 违法和不良信息举报电话：0755-83514034 邮箱：bwb@stcn.com 11月12日，北大医药股份有限公司（简称北大医药）公告，公司于近日经有关部门核实，获悉公司董事 长、总裁徐晰人因涉嫌刑事犯罪，已被重庆市江北区人民检察院批准逮捕。 此前，北大医药曾公告，公司董事长、总裁徐晰人被刑事拘留，正在配合相关部门调查，暂时无法正常履 职。 北大医药主要从事化学药品制剂的研发、生产和销售，医药流通以及医疗服务等业务。其制剂产品主要覆 盖抗感染类、镇痛类、精神类、消化系统类、心血管类等。其流通业务通过北医医药、武汉叶开泰两家全 资子公司，从事第三方药品、器械和耗材的分销、零售、医院集采、药房托管等业务。 西南合成医药集团为北大医药第一大股东，直接持股22.22%。徐晰人通过西南合成医药集团间接持有北 大医药132,455,475股股份，占总股本比例为22.22%，为北大医药实际控制人。 简历显示，徐晰人于1979年4月出生。2025年4月，北 ...

Core Viewpoint - The chairman and president of Beijing University Pharmaceutical Co., Ltd., Xu Xiren, has been arrested for suspected criminal activity, leading to temporary changes in leadership roles within the company [1][3][4]. Group 1: Leadership Changes - Xu Xiren has been approved for arrest by the Jiangbei District People's Procuratorate of Chongqing due to criminal allegations [1][3]. - Director Chen Yuezhong is temporarily acting as chairman, while Executive Vice President Yu Mengchuan is acting as president and legal representative [1][4]. - The company's control has not changed, and the board of directors is functioning normally [1][4]. Group 2: Company Operations - Financial and operational management of the company remains normal despite the leadership changes [1][4]. - The company will continue to monitor the situation and fulfill its information disclosure obligations [1][4].

Core Viewpoint - The chairman and president of Beijing University Pharmaceutical, Xu Xiren, has been arrested for suspected criminal activities, but the company's control and operations remain stable [1][4]. Company Overview - Beijing University Pharmaceutical was established in 1965 as Southwest Synthetic Pharmaceutical Factory and successfully listed on the Shenzhen Stock Exchange in 1997 [4]. - The company is primarily engaged in drug research, production, and sales, recognized as a national innovative pilot enterprise and a key high-tech enterprise under the National Torch Program [4]. Management Changes - Following Xu Xiren's arrest, director Chen Yuezhong has been authorized to act as chairman, while executive vice president Yu Mengchuan has been authorized to act as president and legal representative [1][4]. - The company's board of directors continues to operate normally, and there has been no change in control [1].

11月12日晚间，北大医药公告，公司董事长、总裁徐晰人因涉嫌刑事犯罪已被重庆市江北区人民检察院批准逮捕。此前公司于2025年10月25 日、10月30日披露了徐晰人因被刑事拘留暂时无法正常履职的情况。 公告显示，目前公司董事陈岳忠根据授权代为行使董事长职责，常务副总裁余孟川根据授权代为行使总裁及法定代表人职责。公司强调控制权 未发生变化，董事会运作正常，公司财务及生产经营管理情况正常。 编辑丨钉钉 ...

截至目前，公司董事陈岳忠根据授权代为行使董事长职责，公司常务副总裁余孟川根据授权代为行使总 裁及法定代表人职责。公司控制权未发生变化，公司董事会运作正常，公司财务及生产经营管理情况正 常。 转自：证券时报 人民财讯11月12日电，北大医药(000788)11月12日公告，公司近日经有关部门核实，获悉公司董事长、 总裁徐晰人因涉嫌刑事犯罪，已被重庆市江北区人民检察院批准逮捕。 ...

Group 1 - Peking University Medicine's chairman Xu Xiren has been arrested for criminal charges, but the company's control remains unchanged and operations are normal [3] - Victory Shares plans to issue shares and pay cash to acquire assets, along with raising supporting funds, following a significant stock price fluctuation [4] - Bangji Technology has terminated a major asset restructuring due to failure to reach an agreement with the counterparty, after experiencing a significant stock price decline [5] Group 2 - ST Songfa has completed a major asset restructuring, changing its main business from ceramics to shipbuilding and high-end equipment [6] - Oriental Yuhong plans to sell certain properties, expecting to incur an asset disposal loss of 25.81 million yuan, which exceeds 10% of its audited net profit [7] - Baili Tianheng has decided to delay its global issuance and listing of H-shares due to current market conditions [8] Group 3 - Transsion Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image [9] - Shengtun Mining intends to invest approximately 1.423 billion yuan in its wholly-owned subsidiary Shengtun Gold International [11] - Haibo Sichuang has signed a strategic cooperation agreement with CATL, committing to a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [12] Group 4 - Century Huatong plans to repurchase shares worth between 500 million and 1 billion yuan, with a maximum repurchase price of 28.77 yuan per share [14] - Shannon Chip Innovation's major shareholder has reduced its stake by 549,200 shares, bringing its holding below 5% [16] - Fangzheng Electric's shareholder Zhang Min has reduced his stake by 1.6324 million shares, now holding 5% of the total shares [17] Group 5 - Longjian Co. has won a project worth 483 million yuan for road maintenance in Heilongjiang Province [21][22] - Zhejiang Communications has been awarded a project estimated at 11.103 billion yuan for new urbanization construction in Tonglu County [23] - Dash Smart has secured a project for the intelligent construction of the new Huanggang Port, with a contract value of 55.06 million yuan [24]

截至公告披露日，公司董事陈岳忠先生根据授权代为行使董事长职责，公司常务副总裁余孟川先生根据 授权代为行使总裁及法定代表人职责。公司控制权未发生变化，公司董事会运作正常，公司财务及生产 经营管理情况正常。 智通财经APP讯，北大医药(000788.SZ)发布公告，公司于近日经有关部门核实，获悉公司董事长、总裁 徐晰人先生因涉嫌刑事犯罪，已被重庆市江北区人民检察院批准逮捕。 ...

新京报贝壳财经讯 11月12日，北大医药(000788.SZ)公告称，公司董事长、总裁徐晰人因涉嫌刑事犯 罪，E被重庆市江北区人民检察院批准逮捕。目前，公司董事陈岳忠代为行使董事长职责，常务副总裁 余孟川代为行使总裁及法定代表人职责。公司控制权未发生变化，董事会运作正常，财务及生产经营管 理情况正常。公司将持续关注并履行信息披露义务。 ...

南财智讯11月12日电，北大医药公告，北大医药股份有限公司于近日收到持股5%以上股东北大医疗管 理有限责任公司通知，获悉北大医疗持有的公司部分股份办理了解除质押手续。本次解除质押股份数量 为34,615,386股，占其所持股份比例的51.52%，占公司总股本比例的5.81%。质权人为中国银行股份有 限公司深圳东门支行，解除日期为2025年11月11日。本次解除质押后，北大医疗累计质押公司股份数量 为0股。 ...